Inventor

Michael Gerg

Inventor
Munich, DE

Overview

17→
Patents
2013–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 17 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes20%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
G01NInvestigating or analysing materials by determining their chemical or physical properties19%
C12NMicroorganisms or enzymes8%
C12YEnzymes8%
PatentTitleYear
10,982,007Detection of a posttranslationally modified polypeptide by a bivalent binding agent202110,808,038HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2202010,647,765Amino acid sequence presenting fusion polypeptide and its use202010,626,177HER3 antigen binding proteins binding to the beta-hairpin of HER3202010,564,151Method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto202010,364,290Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4201910,301,383Antibody specifically binding to insulin-like growth factor-1201910,179,815Antibodies specifically binding to HER320199,938,340Amino acid sequence presenting fusion polypeptide and its use20189,840,565'HER1 antigen binding proteins binding to the beta-hairpin of HER1'20179,783,611'Anti-HER3 antibodies binding to the beta-hairpin of HER3'20179,725,511'Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4'20179,725,512'HER3 antibodies binding to the beta-hairpin of HER3'20179,273,144'Antibody specifically binding to insulin-like growth factor-1'20169,266,962'Amino acid sequence presenting fusion polypeptide and its use'20168,658,109'Use of a bis-maleic anhydride cross-linking agent for fixation of a cell or tissue sample'20148,460,944'Use of a bis-maleic anhydride cross-linking agent for fixation of a cell or tissue sample'2013

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2013–2016Patents assigned to ROCHE DIAGNOSTICS OPERATIONS (3)· patent assignee history
2013–2016Patents assigned to GERG MICHAEL (2)· patent assignee history
2013–2021Based in Munich, DE· patent location history
2016–2020Patents assigned to HOFFMANN LA ROCHE (10)· patent assignee history
2016Patents assigned to ANDRES HERBERT (1)· patent assignee history
2019–2021Patents assigned to ROCHE DIAGNOSTICS OPERATIONS INC (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
HOFFMANN LA ROCHE102016–2020
ROCHE DIAGNOSTICS OPERATIONS32013–2016
ROCHE DIAGNOSTICS OPERATIONS INC32019–2021
GERG MICHAELself22013–2016
ANDRES HERBERT12016
Locations
LocationPatentsSpan
Munich, DE172013–2021